Fatty Liver Disease and Multi-System Complications | EK28

Mar 22, 2021 ‐ Mar 24, 2021



Sessions

[Joint Session] Welcoming Remarks and Keynote Session

Mar 22, 2021 10:00am ‐ Mar 22, 2021 11:10am

Co-Chair(s):

Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Mar 22, 2021 10:35am ‐ Mar 22, 2021 11:10am

Speaker(s):

A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Mar 22, 2021 11:10am ‐ Mar 22, 2021 11:35am

Speaker(s):

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Mar 22, 2021 11:10am ‐ Mar 22, 2021 1:00pm

Co-Chair(s):

Coffee BreakCoffee Break

Preview Available

Coffee Break

Mar 22, 2021 11:35am ‐ Mar 22, 2021 11:55am


The Gut-Liver Axis in Liver Cancer Risk Conditions

Mar 22, 2021 11:55am ‐ Mar 22, 2021 12:20pm

Speaker(s):

Lipid Dysregulation in Inflammation, NASH, and Cancer

Mar 22, 2021 12:20pm ‐ Mar 22, 2021 12:45pm

Speaker(s):

Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Mar 22, 2021 12:45pm ‐ Mar 22, 2021 1:00pm

Speaker(s):

[Joint Session] Career Roundtable

Mar 22, 2021 2:30pm ‐ Mar 22, 2021 3:30pm

Panelist(s):

[Joint Session] Live Poster Session Day 1

Mar 22, 2021 4:00pm ‐ Mar 22, 2021 5:00pm

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content